Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission
After a diagnosis of Stimulant dependence including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones, and often following a treatment episode or other intervention (including self-intervention), the person has been abstinent from amphetamine or other stimulants for 12 months or longer.
Differential diagnosis
When diagnosing Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission, the following ICD-11 disorders should be considered in the differential diagnosis:
- Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0)
- Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu (6C46.1)
Frequently asked questions
What disorders are in the differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission?
The differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission (6C46.23) includes: Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu (6C46.1).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C46.23 – WHO ICD-11
Open in interactive browser →